Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function

Alzheimer s & Dementia(2024)10.1002/alz.13858Source: DataRank Database

A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function is a research paper published in Alzheimer s & Dementia (2024). On theSindex it has a DataRank of 0. It has been cited 80 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access80 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: hybridTopics (108)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Zachary Hausle,Hirotaka Iwaki ORCID,Pamela Thropp ORCID,Jennifer Lamoureux,Edward B. Lee ORCID

Live enrichment

PubMed:38770829 PMC:PMC11350010

National Institute of Neurological Disorders and Stroke

Grant: AG000546

National Institutes of Health

Grant: U01 AG024904

NIA NIH HHS

Grant: P30 AG072979

NIA NIH HHS

Grant: U19 AG024904

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5K08AG000546-05

GROWTH HORMONE AND MUSCLE STRENGTH

National Institutes of Health

Grant: 1U01AG024904-01

Alzheimers Disease Neuroimaging Initiative

National Institutes of Health

Grant: 3U19AG024904-18S3

Alzheimer's Disease Neuroimaging Initiative (ADNI4)

NIH/NIA

hybridLicense: cc-by-nc-nd

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13858

publisherhttps://alz-journals.onlinelibrary.wiley.com/doi/pdf/10.1002/alz.13858

repositoryhttps://escholarship.org/content/qt6kd1j7bq/qt6kd1j7bq.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11350010/pdf/ALZ-20-5114.pdf

Unpaywallhttps://escholarship.org/uc/item/6kd1j7bq

Fields of Study

0301 basic medicine0302 clinical medicine03 medical and health sciences

MeSH Terms

BrainLewy BodiesHumansAlzheimer Diseasetau ProteinsPrevalenceSensitivity and SpecificityCross-Sectional StudiesCognitionAgedAged, 80 and overFemaleMalealpha-SynucleinAmyloid beta-PeptidesNeuroimagingBiomarkersCognitive Dysfunction

Keywords

Alzheimer's diseaseLewy BodySaaCo‐pathologyMaleAgingBiological PsychologyNeurodegenerativeAcquired Cognitive Impairment (rcdc)alpha-Synuclein (mesh)Aging (rcdc)CognitionBrain Disorders (rcdc)Amyloid beta-Peptides (mesh)Cognitive Dysfunction (mesh)1103 Clinical Sciences (for)80 and overDementia (rcdc)80 and over (mesh)PrevalencePsychology2.1 Biological and endogenous factors32 Biomedical and Clinical Sciences (for-2020)Male (mesh)Alzheimer's Disease Related Dementias (ADRD)Neurosciences (rcdc)Neurodegenerative (rcdc)Alzheimer Disease (mesh)Aged, 80 and overHumans (mesh)Alzheimer's Disease (rcdc)52 Psychology (for-2020)Brain3209 Neurosciences (for-2020)Prevalence (mesh)Alzheimer's Disease Related Dementias (ADRD) (rcdc)Biomarkers (mesh)4.2 Evaluation of markers and technologies (hrcs-rac)Neurological5202 Biological Psychology (for-2020)alpha-SynucleinFemaleSensitivity and Specificity (mesh)Behavioral and Social Science (rcdc)4.2 Evaluation of markers and technologiesResearch ArticleCognition (mesh)Clinical Sciences610tau ProteinsNeuroimagingGeriatrics (science-metrix)Sensitivity and SpecificityNeuroimaging (mesh)Cross-Sectional Studies (mesh)Brain (mesh)Alzheimer DiseaseBehavioral and Social Science616Acquired Cognitive ImpairmentHumansCognitive Dysfunction3202 Clinical Sciences (for-2020)AgedSeed Amplification Assay (SAA)Amyloid beta-PeptidesBiomedical and Clinical SciencesNeurological (hrcs-hc)Aged (mesh)4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac)NeurosciencesAlzheimer's Disease Neuroimaging InitiativeAlzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)2.1 Biological and endogenous factors (hrcs-rac)1109 Neurosciences (for)Brain Disorders4.1 Discovery and preclinical testing of markers and technologiesCross-Sectional Studiesco-pathologyGeriatricsFemale (mesh)Lewy Bodies (mesh)DementiaAlzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD) (rcdc)Lewy Bodiestau Proteins (mesh)Biomarkers